Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
(Approval lapsed) TEVA-PRAZOSIN (Prazosin hydrochloride) 2mg tablets
Section 19A approved medicine
(Approval lapsed) TEVA-PRAZOSIN (Prazosin hydrochloride) 2mg tablets
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
MINIPRESS prazosin 2 mg (as hydrochloride) tablet blister pack - ARTG 10757
APO-PRAZOSIN prazosin (as hydrochloride) 2mg tablet blister pack - ARTG 73862
APO-PRAZOSIN prazosin (as hydrochloride) 2mg tablet blister pack - ARTG 73862
Indication(s)
In Patients with Hypertension.
Indicated in the treatment of hypertension of varied aetiology and all grades of severity. It can be used as the initial and sole agent or it may be employed in a treatment programme in conjunction with other antihypertensive agents.
Additional information
Please note overseas product is not approved for the treatment of congestive heart failure, Raynaud's Phenomenon, Raynaud's Disease or Benign Prostatic Hyperplasia